Vor Biopharma Inc. Research And Development Expense

Quick Answer

Vor Biopharma Inc. reported Research And Development Expense of $321.53 million for the year ending 2025.

  • Vor Biopharma Inc. showed an increase of +244.6% in Research And Development Expense from 2024 to 2025.
  • This data is from Vor Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Vor Biopharma Inc.'s Research And Development Expense has grown by 916.9%.
  • Historical annual values: Fiscal year 2025: $321.53 million | Fiscal year 2024: $93.31 million | Fiscal year 2023: $94.32 million | Fiscal year 2022: $64.55 million | Fiscal year 2021: $47.53 million | Fiscal year 2020: $31.62 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: